![]() |
Mesenchymal stem cells : biological concepts, current advances, opportunities, and challenges / Leisheng Zhang ... [et al.]. -- London : Elsevier, 2023. – (58.155/Z63) |
Contents
Contributors
1. Introduction of mesenchymal stem/stromal cells
1.1 The definition of MSCs
1.2 The characteristics and biology of MSCs
1.3 The classification of MSCs
1.4 The origins and development of MSCs
1.5 The safety and efficacy of MSCs
1.6 The regulation and molecular mechanism of MSCs
1.7 The standardization and industrialization of MSCs
Acknowledgment
Conflict of interest
References
2. The application of MSCs in regenerative medicine
2.1 The application of MSCs in hematological diseases
2.2 The application of MSCs in digestive diseases
2.3 The application of MSCs in neurological diseases
2.4 The application of MSCs in endocrine diseases
2.5 The application of MSCs in immune diseases
2.6 The application of MSCs in movement diseases
2.7 The application of MSCs in respirator/diseases
2.8 The application of MSCs in urogenital diseases
Acknowledgment
Conflict of interest
References
3. Biomaterials and MSCs composites in regenerative medicine
3.1 Introduction to the types and characteristics of stem cells
3.2 Introduction to biomaterials and tissue engineering
3.3 Construction and application of different biomaterials/MSC composites
3.4 Biomaterials and intermittent stem cells
3.5 Other aspects
Acknowledgments
References
4. The enhanced therapeutic potential of MSC with biomaterials application
4.1 Introduction
4.2 MSCs-based therapy
4.3 Challenges for MSCs-based therapy
4.4 Characteristics of biomaterials
4.5 Classification of biomaterials
4.6 Three-dimensional culture of MSCs with biomaterials
4.7 Therapeutic potential of MSC with biomaterials
4.8 Conclusion
Acknowledgements
References
5. Mesenchymal stem cells: A promising weapon for cancer therapy
5.1 Introduction
5.2 The potential of MSCs for cancer therapy
5.3 The advantages and limitations of MSCs in cancer therapy
5.4 Modification strategies to enhance MSC therapy
5.5 Modified MSCs in cancer therapeutics
5.6 Conclusion and future perspectives
Acknowledgements
References
Index